ONO PHARMA USA continues to expand its organization for enhancement of R&D activities and future commercialization opportunities in the U.S.
CAMBRIDGE, Mass., Aug. 31, 2022 /PRNewswire/ — ONO PHARMA USA, INC. (President and CEO, Kunihiko Ito, “OPUS”) announces…